Baker Ellis Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $235K | Hold |
1,200
| – | – | 0.03% | 231 |
|
|
2025
Q4 | $208K | Hold |
1,200
| – | – | 0.03% | 247 |
|
|
2025
Q3 | $229K | Hold |
1,200
| – | – | 0.03% | 227 |
|
|
2025
Q2 | $216K | Sell |
1,200
-20
| -2% | -$3.47K | 0.03% | 203 |
|
|
2025
Q1 | $206K | Buy |
+1,220
| New | +$200K | 0.03% | 207 |
|
|
2023
Q1 | – | Sell |
-1,300
| Closed | -$203K | – | 212 |
|
|
2022
Q4 | $203K | Buy |
+1,300
| New | +$187K | 0.04% | 193 |
|
|
2022
Q1 | – | Sell |
-1,300
| Closed | -$225K | – | 213 |
|
|
2021
Q4 | $225K | Buy |
+1,300
| New | +$198K | 0.04% | 196 |
|
|
2020
Q3 | – | Sell |
-1,400
| Closed | -$160K | – | 174 |
|
|
2020
Q2 | $160K | Hold |
1,400
| – | – | 0.05% | 166 |
|
|
2020
Q1 | $112K | Sell |
1,400
-200
| -13% | -$20.7K | 0.04% | 166 |
|
|
2019
Q4 | $171K | Hold |
1,600
| – | – | 0.05% | 170 |
|
|
2019
Q3 | $171K | Hold |
1,600
| – | – | 0.05% | 185 |
|
|
2019
Q2 | $163K | Hold |
1,600
| – | – | 0.04% | 187 |
|
|
2019
Q1 | $144K | Sell |
1,600
-100
| -6% | -$8.66K | 0.04% | 185 |
|
|
2018
Q4 | $142K | Hold |
1,700
| – | – | 0.04% | 180 |
|
|
2018
Q3 | $183K | Hold |
1,700
| – | – | 0.05% | 188 |
|
|
2018
Q2 | $187K | Hold |
1,700
| – | – | 0.05% | 187 |
|
|
2018
Q1 | $171K | Sell |
1,700
-100
| -6% | -$10.2K | 0.04% | 189 |
|
|
2017
Q4 | $177K | Sell |
1,800
-450
| -20% | -$42.7K | 0.04% | 191 |
|
|
2017
Q3 | $211K | Hold |
2,250
| – | – | 0.06% | 185 |
|
|
2017
Q2 | $250K | Hold |
2,250
| – | – | 0.07% | 180 |
|
|
2017
Q1 | $221K | Hold |
2,250
| – | – | 0.06% | 185 |
|
|
2016
Q4 | $207K | Buy |
2,250
+100
| +5% | +$8.62K | 0.06% | 188 |
|
|
2016
Q3 | $182K | Hold |
2,150
| – | – | 0.05% | 196 |
|
|
2016
Q2 | $175K | Hold |
2,150
| – | – | 0.05% | 194 |
|
|
2016
Q1 | $154K | Sell |
2,150
-100
| -4% | -$6.71K | 0.05% | 202 |
|
|
2015
Q4 | $160K | Hold |
2,250
| – | – | 0.05% | 202 |
|
|
2015
Q3 | $138K | Sell |
2,250
-100
| -4% | -$6.99K | 0.05% | 218 |
|
|
2015
Q2 | $170K | Hold |
2,350
| – | – | 0.06% | 211 |
|
|
2015
Q1 | $181K | Buy |
+2,350
| New | +$168K | 0.06% | 209 |
|
|
2013
Q3 | – | Sell |
-2,700
| Closed | -$164K | – | 244 |
|
|
2013
Q2 | $164K | Buy |
+2,700
| New | +$161K | 0.07% | 208 |
|
Other funds holding DGX
VCM
VPM
EIG
Baker Ellis Asset Management's DGX Position: Q1 2026 in Review
Baker Ellis Asset Management held its Quest Diagnostics (DGX) position steady in Q1 2026 at 1,200 shares worth $235K. The position accounts for 0.03% of the portfolio, ranked #231.
Baker Ellis Asset Management first reported a position in DGX in Q2 2013 and has held it in 30 quarters since. The position peaked at $250K in Q2 2017. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Baker Ellis Asset Management held 1,200 shares of Quest Diagnostics worth $235K as of Q1 2026.
- Baker Ellis Asset Management left its Quest Diagnostics share count unchanged in Q1 2026.
- Quest Diagnostics made up 0.03% of Baker Ellis Asset Management's portfolio in Q1 2026, its #231 holding.
- Baker Ellis Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 30 quarters since.
- Baker Ellis Asset Management's Quest Diagnostics position peaked at $250K in Q2 2017.
- 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Baker Ellis Asset Management's 13F filing for Q1 2026, filed 17 Apr 2026.